Saturday, July 11, 2026

Drug profile · INN

maintenance

maintenance is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 5
Pipeline programs 18
News articles 0
Drug details — maintenance
Class
Route
Patents
5
Programs
18
Data quality
0.70

Quick answer

maintenance is an FDA-listed pharmaceutical active ingredient.

Key facts

INN maintenance

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. 2021/3336 Phase 3 · George Institute for · Maintenance treatment in metastatic non-squamous lung cancer
  2. JPB898 (Induction and Maintenance) Phase 3 · Sandoz (Japan) · Melanoma
  3. Ramelteon Phase 3 · Takeda · Sleep Initiation and Maintenance Disorders
  4. Tibsovo 250 mg film-coated tablets Phase 3 · George Institute for · ivosidenib maintenance after SOC adjuvant chemotherapy in cu
  5. CAR-T Cell Therapy + Chidamide and PD-1 Inhibitor Maintenance Phase 2 · Daihong Liu · Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DL
  6. CCRT with Maintenance Tislelizumab and Metronomic Capecitabine Phase 2 · BEONE MEDICINES AUS · Nasopharyngeal Carcinoma
  7. DRI19220 Phase 2 · Sanofi-Aventis U.S · Hidradenitis suppurativa
  8. DURVALUMAB, Ceralasertib Phase 2 · Istituto Gentili Italia · Stage III NSCLC patients with loco-regional relapse > 12 mon

Related patents

  1. US 10265372

    Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 8961955

    Maintenance and propagation of mesenchymal stem cells

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 8728724

    Identification of micro-RNAs involved in neuromuscular synapse maintenance and regeneration

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 8202848

    Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7784616

    Dispenser for progestin used for acute maintenance treatment of DUB

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is maintenance?

maintenance is an FDA-listed pharmaceutical active ingredient.